FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission

Beauverd, Yan; Tsopra, Olga; Roosnek, Eddy Emile; Simon, Audrey; Grandjean, Anne-Pascale; Tirefort, Yordanka; Dantin, Carole Alice; Masouridi Levrat, Stavroula; Chalandon, Yves

doi:10.1002/hon.2272

Scientific article

English

FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission

ContributorsBeauverd, Yan; Tsopra, Olga; Roosnek, Eddy Emile; Simon, Audrey; Grandjean, Anne-Pascale; Tirefort, Yordanka; Dantin, Carole Alice; Masouridi Levrat, Stavroula; Chalandon, Yves

Published inHematological oncology, vol. 35, no. 3, p. 392-394

Publication date2017

Affiliation entities

Faculté de médecine

Research groups

Citation (ISO format)

BEAUVERD, Yan et al. FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission. In: Hematological oncology, 2017, vol. 35, n° 3, p. 392–394. doi: 10.1002/hon.2272

Article (Published version)

Identifiers

PID : unige:84044
DOI : 10.1002/hon.2272
PMID : 26563907

Journal ISSN0278-0232

524views

3downloads

Creation27/01/2016 11:56:00

First validation27/01/2016 11:56:00

Update time15/03/2023 00:23:49

Status update15/03/2023 00:23:49

Last indexation19/11/2024 15:02:51

Archive ouverte UNIGE

FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission

Technical informations